Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Cancer Res. 2012 Feb 14;72(7):1717–1727. doi: 10.1158/0008-5472.CAN-11-3758

Figure 3. Accumulation of Nanog through sequential rounds of vaccination.

Figure 3

(A) VICE was applied, and levels of Nanog mRNA were measured by real-time RT-PCR and normalized to levels of β-actin mRNA (top). Representative image of the RT-PCR end-product (bottom). (B) The frequency of Nanog+ cells at each stage of immunoediting was measured by immunofluorescence analysis. (C) The percentage of Nanog+ cells was quantified. Data are representative of three independent experiments.